Advertisement

Supply Chain



Abbott will spend $37.6 million to open a medical device manufacturing facility in Westfield, Ind., according to the Indianapolis Business Journal.

The FDA warned providers and patients Oct. 28 of risks associated with Endologix's AFX endovascular grafts, which are used to treat abdominal aortic aneurysms. 

Advertisement

Most Read

Advertisement
Advertisement